Trial Profile
Metronomic vinorelbine in patients with metastatic tumors: phase II translational study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Oct 2013
Price :
$35
*
At a glance
- Drugs Vinorelbine (Primary)
- Indications Advanced breast cancer; Non-small cell lung cancer; Prostate cancer
- Focus Therapeutic Use
- 16 Sep 2008 Results presented at ESMO 2008.
- 27 Feb 2008 Status changed from recruiting to completed, according to ClinicalTrials.gov
- 19 Nov 2006 New trial record.